Doctor
Innovative technologies for cataract refractive surgery.
The development of new IOLs is in progress and some hi-tech IOLs are already undergoing clinical trials to strike the more and more challenging goals of contemporary cataract surgery.
The development of new IOLs is in progress and some hi-tech IOLs are already undergoing clinical trials to strike the more and more challenging goals of contemporary cataract surgery. The......
LeggiSize and location decisive in treatment outcome
Retinal haemangioblastoma is a rare disease that is difficult to manage, involving a careful assessment of the balance between potential visual loss caused by the tumour vs visual loss induced by therapeutic treatments. When......
LeggiInsufficient pupillary dilation with normal mydriatic drugs can be caused by pathological or paraphysiological precedents in the iris; the most frequent are the presence of posterior synechiae (due to previous uveitic facts or previous surgery or prolonged use of myotics) and atrophy and sclerosis of the iris stroma and pupillary sphincter (capsular pseudoexfoliation syndrome or due to tissue senescence facts alone).
A new association between poor mydriasis and the use of tamsulosin (Pradifâ, Omnicâ), an a-1A receptor blocker, has recently been described (1). This drug is used to treat patients with......
LeggiIdiopathic sub-retinal neovascularisations In subjects under 50 years of age, the finding of a sub-retinal neovascular membrane (CNV) should promote investigations to exclude associated causes, first......
LeggiStargardt syndrome is a genetic disorder that leads to severe low vision in adolescents and adults. Clinically it is relatively well known, but there is an apparent lack of interest in the psycho-social aspects related to......
LeggiNew challenges in IOL development
Cataract extraction is currently considered not only a therapeutic procedure, but also a refractive surgical procedure. Indeed, while the accuracy of visual and refractive results is improving......
LeggiAcanthamoeba keratitis: PHMB treatment selected as 'hot topic' at the ARVO 2015 congress
Appointment in Denver (USA) from 3 to 7 May 2015 for the annual ARVO congress. This year, among the abstracts admitted to the prestigious congress sponsored by the Association for Vision Research......
LeggiCataract surgery and antibiotic prophylaxis with netilmycin: 'Hot Topic' at A.R.V.O. 2015
Antibiotic prophylaxis in cataract surgery is a highly topical issue and the subject of lively debate among specialists. In this regard, the Congress Programme Committee......
LeggiCongressi
- Nationals
- Internationals
